Correlation Between Bio Gene and Iron Road
Can any of the company-specific risk be diversified away by investing in both Bio Gene and Iron Road at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Iron Road into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and Iron Road, you can compare the effects of market volatilities on Bio Gene and Iron Road and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Iron Road. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Iron Road.
Diversification Opportunities for Bio Gene and Iron Road
Modest diversification
The 3 months correlation between Bio and Iron is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Iron Road in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iron Road and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Iron Road. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iron Road has no effect on the direction of Bio Gene i.e., Bio Gene and Iron Road go up and down completely randomly.
Pair Corralation between Bio Gene and Iron Road
Assuming the 90 days trading horizon Bio Gene Technology is expected to generate 1.71 times more return on investment than Iron Road. However, Bio Gene is 1.71 times more volatile than Iron Road. It trades about 0.0 of its potential returns per unit of risk. Iron Road is currently generating about -0.03 per unit of risk. If you would invest 8.30 in Bio Gene Technology on December 2, 2024 and sell it today you would lose (5.00) from holding Bio Gene Technology or give up 60.24% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bio Gene Technology vs. Iron Road
Performance |
Timeline |
Bio Gene Technology |
Iron Road |
Bio Gene and Iron Road Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bio Gene and Iron Road
The main advantage of trading using opposite Bio Gene and Iron Road positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Iron Road can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iron Road will offset losses from the drop in Iron Road's long position.Bio Gene vs. Spirit Telecom | Bio Gene vs. Lunnon Metals | Bio Gene vs. Hotel Property Investments | Bio Gene vs. Platinum Asset Management |
Iron Road vs. Collins Foods | Iron Road vs. Everest Metals | Iron Road vs. FireFly Metals | Iron Road vs. Truscott Mining Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |